Importer of Controlled Substances Application: Shertech Laboratories, LLC, 18277 [2020-06762]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 63 / Wednesday, April 1, 2020 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF LABOR
Drug Enforcement Administration
Office of the Secretary
[Docket No. DEA–614]
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Cadmium
in General Industry Standard
Importer of Controlled Substances
Application: Shertech Laboratories,
LLC
ACTION:
Notice of availability; request
for comments.
ACTION:
Notice of application.
Registered bulk manufacturer of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 1, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 1, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 21, 2020,
Shertech Laboratories, LLC, 1185 Woods
Chapel Road, Duncan, South Carolina
29334 applied to be registered as an
importer of the following basic class(es)
of a controlled substance:
DATES:
Controlled substance
jbell on DSKJLSW7X2PROD with NOTICES
Cocaine ........................
Drug
code
Schedule
9041
II
The company plans to import
synthetic derivatives of the listed
controlled substance in bulk form to
conduct clinical trials. Approval of
permit applications will occur only
when the registrant’s activity is
consistent with what is authorized
under to 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–06762 Filed 3–31–20; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:31 Mar 31, 2020
Jkt 250001
The Department of Labor
(DOL) is submitting this Occupational
Safety and Health Administration
(OSHA)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that agency receives
on or before May 1, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) Whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) if the
information will be processed and used
in a timely manner; (3) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (4)
ways to enhance the quality, utility and
clarity of the information collection; and
(5) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
automated collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT:
Frederick Licari by telephone at 202–
693–8073, TTY 202–693–8064, (these
are not toll-free numbers) or by email at
DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The
Occupational Safety and Health Act of
1970 (the OSH Act) (29 U.S.C. 651 et
seq.) authorizes information collection
by employers as necessary or
appropriate for enforcement of the OSH
Act, or for developing information
regarding the causes and prevention of
occupational injuries, illnesses, and
accidents (see 29 U.S.C. 657). The OSH
SUMMARY:
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
18277
Act also requires OSHA to obtain such
information with a minimum burden
upon employers, especially those
operating small businesses, and to
reduce to the maximum extent feasible
unnecessary duplication of effort in
obtaining said information (see 29
U.S.C. 657). The collection of
information specified in the Cadmium
in General Industry Standard (29 CFR
1910.1027) protects workers from the
adverse health effects that may result
from their exposure to cadmium. The
major collection of information of the
standard include: Conducting worker
exposure monitoring; notifying workers
of their cadmium exposures;
implementing a written compliance
program; implementing medical
surveillance of workers; providing
examining physicians with specific
information; ensuring that workers
receive a copy of their medical
surveillance results; maintaining
workers’ exposure monitoring and
medical surveillance records for specific
periods; and providing access to these
records to the workers who are the
subject of the records, the worker’s
representative, and other designated
parties. For additional substantive
information about this ICR, see the
related notice published in the Federal
Register on November 1, 2019 (84 FR
58747).
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–OSHA.
Title of Collection: Cadmium in
General Industry Standard.
OMB Control Number: 1218–0185.
Affected Public: Private Sector:
Businesses or other for-profits.
Total Estimated Number of
Respondents: 50,679.
Total Estimated Number of
Responses: 234,036.
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 85, Number 63 (Wednesday, April 1, 2020)]
[Notices]
[Page 18277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06762]
[[Page 18277]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-614]
Importer of Controlled Substances Application: Shertech
Laboratories, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturer of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 1, 2020.
Such persons may also file a written request for a hearing on the
application on or before May 1, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 21, 2020, Shertech Laboratories, LLC, 1185
Woods Chapel Road, Duncan, South Carolina 29334 applied to be
registered as an importer of the following basic class(es) of a
controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cocaine................................ 9041 II
------------------------------------------------------------------------
The company plans to import synthetic derivatives of the listed
controlled substance in bulk form to conduct clinical trials. Approval
of permit applications will occur only when the registrant's activity
is consistent with what is authorized under to 21 U.S.C. 952(a)(2).
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-06762 Filed 3-31-20; 8:45 am]
BILLING CODE 4410-09-P
